(Q43413741)

23 November 2017

title

Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine (English)

1 reference

23 November 2017

1 reference

0 references

Marc Weiner

1

1 reference

23 November 2017

William Burman

2

1 reference

23 November 2017

Andrew Vernon

3

1 reference

23 November 2017

Debra Benator

4

1 reference

23 November 2017

Charles A Peloquin

5

1 reference

23 November 2017

Awal Khan

6

1 reference

23 November 2017

Stephen Weis

7

1 reference

23 November 2017

Barbara King

8

1 reference

23 November 2017

Nina Shah

9

1 reference

23 November 2017

Thomas Hodge

10

1 reference

23 November 2017

Tuberculosis Trials Consortium

11

1 reference

23 November 2017

language of work or name

English

0 references

publication date

16 January 2003

1 reference

American Journal of Respiratory and Critical Care Medicine

23 November 2017

published in

1 reference

23 November 2017

volume

167

1 reference

23 November 2017

issue

10

1 reference

23 November 2017

page(s)

1341-1347

1 reference

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-951OC

40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-951OC

Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-951OC

Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-951OC

Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-951OC

A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200208-951OC

10.1164/RCCM.200208-951OC

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference